Updated 6/5/2020: As part of the Medical School Research Reactivation Process guidelines, a wave 2 ramp-up will begin on Monday, June 8th for labs and staff who conduct research within MSRB 1, 2, 3, MBNI, NCRC 14, 23, 35, 36, 60, 90 and NCRC 26 VIVARIUM only. The Vector Core has been approved to reopen for labs and staff who conduct research within these approved buildings.
For the latest Vector Core updates, including new operating procedures, please visit the BRCF Research Reactivation Guidelines.
The Vector Core
produces biological products (gene transfer vectors) that facilitate the transfer of specific genes into either normal or aberrant cells. The Vector Core also provides intellectual and technical advice to researchers regarding the optimal use of these systems. Gene transfer vectors require special handling precautions and manufacturing systems that lend themselves to a core structure that optimizes efficiencies of scale and cost to the research community.
To begin work with the Vector Core, you will first need to register with MiCores and complete training. Please see the Training page for more information on how to get started.
For questions regarding your specific needs or project goals please contact Vector Core Director, Tom Lanigan, to set up a consultation.
- Provide a Core laboratory for the construction, purification, and characterization of recombinant vectors containing genes relevant to the study of disease models for use as in vitro and in vivo gene transfer reagents. These systems include both non-viral (expression plasmid) and viral (recombinant lentivirus, recombinant retrovirus, and recombinant adenovirus) technologies.
- Collaborate closely with researchers to ensure the Vector Core provides the platforms our customers require, and to institute the use of new technologies.
- Maintain qualified staff and provide high quality, cost-effective products to our researchers.
AGC Data Delivery Changes in the Time of UM-RCP
With the recent announcement of the University of Michigan Research Computing Package (UMRCP), the BRCF Advanced Genomics Core (AGC) has been working with Information and Technology Services (ITS) to update our data delivery strategy. The Michigan Medicine version of the …Services
Announcing New Managing Director for the BRCF Microscopy Core
Biomedical Research Core Facilities is pleased to announce that Jennifer Peters, Ph.D., is the new Managing Director of the BRCF Microscopy Core, effective Aug 2, 2021. Dr. Jennifer Peters experience includes nearly 20 years of utilizing microscopy and imaging techniques …Staff Breaking News
NanoString GeoMx DSP: Morphology Driven High Plex Spatial Analysis of Genomic and Proteomic targets
Wednesday, September 30, 2021 @ 1:00 pm Presented By: NanoString and the BRCF Advanced Genomics Core Spatial genomics and transcriptomics is a rapidly evolving area of research that enables correlation of the expression of tens of thousands of genes and …Event